Close window

Disclosure according to sec. 85 German Securities Trading Act and Art. 20 MAR for company APONTIS PHARMA AG:

  • The company compiling the analysis or an affiliated company had reached an agreement on the compilation of the research recommendation with the analysed company.
  • Markings in the chart show rating changes by Warburg Research GmbH in the last 12 months. Every marking details the date and closing price on the day of the rating change.
    Recommendation/Target Price History

    Date Recommendation Target Price Close Price Analyst
    14.02.2024 Buy 18.00 EUR 6.00 EUR Christian Ehmann
    09.01.2024 Buy 20.00 EUR 4.52 EUR Christian Ehmann
    06.11.2023 Buy 19.40 EUR 3.33 EUR Christian Ehmann
    01.08.2023 Buy 21.50 EUR 5.84 EUR Christian Ehmann
    03.05.2023 Buy 26.00 EUR 11.20 EUR Christian Ehmann


    Back to main disclaimer